Christophe Degois

All filings by Christophe Degois on record concern Oncolytics Biotech Inc. In total, 2 filings cover trades dated from 28 May 2024 to 29 January 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 29 January 2025, reports a transaction in Oncolytics Biotech Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.